Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10
Exemestane (EXE) is an irreversible steroidal aromatase inhibitor mainly used as an adjuvant endocrine therapy for postmenopausal women suffering from breast cancer. Besides inhibiting aromatase activity, EXE has multiple biological functions, such as antiproliferation, anti-inflammatory, and antiox...
Saved in:
Main Authors: | Ya-Hui Wang, Rong-Kun Li, Ying Fu, Jun Li, Xiao-Mei Yang, Yan-Li Zhang, Lei Zhu, Qin Yang, Jian-Ren Gu, Xin Xing, Zhi-Gang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2017/3072745 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathological Microenvironment‐Remodeling Nanoparticles to Alleviate Liver Fibrosis: Reversing Hepatocytes‐Hepatic Stellate Cells Malignant Crosstalk
by: Ling‐Feng Zhang, et al.
Published: (2025-01-01) -
Resveratrol Inhibits Hepatic Stellate Cell Activation via the Hippo Pathway
by: Chunxue Li, et al.
Published: (2021-01-01) -
Hepatocyte-derived liver progenitor-like cells attenuate liver cirrhosis via induction of apoptosis in hepatic stellate cells
by: Xu Zhou, et al.
Published: (2025-02-01) -
Liver Fibrosis and Protection Mechanisms Action of Medicinal Plants Targeting Apoptosis of Hepatocytes and Hepatic Stellate Cells
by: Florent Duval, et al.
Published: (2014-01-01) -
PLIN5 contributes to lipophagy of hepatic stellate cells induced by inorganic arsenic
by: Haomiao Li, et al.
Published: (2025-01-01)